Clinical Trial Update: Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial comparing a DPP-4 inhibitor with an SGLT-2 inhibitor in people with Type 2 diabetes mellitus and ischemic heart disease has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor
• SGLT-2 inhibitor

Snippet

Sponsor: Chiang Mai University | Conditions: Diabetes Mellitus, Type 2, Ischemic Heart Disease | Phase 4 | Status: COMPLETED